⌘K

Login Start Free

Home/Filings/4/0001437749-18-003654

4//SEC Filing

KAYSEN DAVID B 4

Accession 0001437749-18-003654

CIK 0001029125other

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:36 PM ET

Size

4.9 KB

Accession

0001437749-18-003654

Insider Transaction Report

Form 4

Period: 2018-02-27

Sun BioPharma, Inc.SNBP

President and CEO

Transactions

Award
Employee Stock Option (right to buy)
2018-02-27+50,000→ 50,000 total
Exercise: $8.10From: 2018-02-27Exp: 2028-02-27→ Common Stock (50,000 underlying)

Documents

1 file

4
rdgdoc.xmlPrimary
KAYSEN GRANT 2-27-18

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeother

Related Parties

1

filerCIK 0001133026

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Mar 1, 4:36 PM ET
Size: 4.9 KB

View on SEC.gov